Glycine alleviates liver injury induced by deficiency in methionine and or choline in rats

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 6, 2012, Pages 728-736

  Barakat, Heba A ^a   Hamza, A H ^a  

^a Ain Shams University   (Egypt)

Author keywords

Choline; Fatty acid transport protein; Glycine; Methionine; Non Alchohlic fatty liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA LEVO FUCOSIDASE; ARGINASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; CHOLESTEROL; CHOLINE; FATTY ACID TRANSPORTER; GLYCINE; LIVER ENZYME; METHIONINE; PROTEIN; TRIACYLGLYCEROL; TUMOR MARKER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINO ACID DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; GENE EXPRESSION; LIPID LIVER LEVEL; LIVER FUNCTION; LIVER INJURY; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; ANTIOXIDANTS; CHOLINE DEFICIENCY; FATTY LIVER; GLYCINE; LIPID METABOLISM; LIPID PEROXIDATION; MALE; METHIONINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84864235980     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. TRAUNER M, ARRESE M, WAGNER M. Fatty liver and lipotoxicity. Biochim Biophys Acta 2010; 1801: 299-310.
2. VETELAINEN R, VAN VLIET A, VAN GULIK TM. Essential pathogenic and metabolic differences in steatosis induced by choline or methionine-choline deficient diets in a rat model. J Gasteroenterol Hepatol 2007; 22: 1526-1533.
3. SEO YS, KIM JH, JO NY, CHOI KM, BAIK SH, PARK JJ, KIM JS, BYUN KS, BAK YT, LEE CH, KIM A, YEON JE. PPAR agonists treatment is effective in a non alcoholic fatty liver disease animal model by modulating fatty-Acid metabolic enzymes. J Gastroenterol Hepatol 2006; 23: 102-109.
4. GYAMFI MA, TANAKA Y, HE L, KLAASSEN CD, WAN YJY. Hepatic effects of a methionine-choline-deficient die in hepatocyte RXRá-null mice. Toxicol Appl Pharmacol 2009; 234: 166-178.
5. KOPPE SWP, SAHAI A, MALLADI P, WHITINGTON PF, GREEN RM. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. J Hepatol 2004; 41: 592-598.
6. SENTHILKUMAR R, NALINI N. Effect of glycine on tissue fatty acid composition in an experimental model of alcohol-induced hepatotoxicity. Clin Exp Pharma Physiol 2004; 31: 456-461.
7. STACHLEWITZ RE, SEABRA V, BRADFORD B. Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: Role of Kupffer cells. Hepatology 1999; 29: 737-745.
8. ZHONG Z, CONNOR HD, YIN M. Dietary glycine and renal deivation prevents cyclosporine A-induced hydroxyl radical production in rat kidney. Mol Pharmacol 1999; 56: 455-463.
9. DETERS M, STRUBELT O, YOUNES M. Protection by glycine against hypoxia-reoxygenation induced hepatic injury. Res Commun Mol Pathol Pharmacol 1997; 97: 199-213.
10. REEVES PG, NIELSEN FH, FAHY GC. AIN-93 Purified diets for laboratory rodents: Final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76 A rodent diet. J Nutr 1993; 123: 1939-1951.
11. VANDESOMPELE J, DE PRETER K, PATTYN F, POPPE B, VAN ROY N, DE PAEPE A, SPELEMAN F. Accurate normalization of real-Time Iuantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002; 3: 1-11.
12. PICARD C, LAMBOTTE L, STARKEL P. Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats. J Hepatol 2002; 32: 645-652.
13. RATZIU V, GIRAL P, CHARLOTTE F, BRUCKERT E, THIBAULT V, THEODOROU I. Liver fibrosis in overweight patients. Gastroenterology 2000; 118: 1117-1123.
14. TENDLER D, LIN S, YANCY JRWS, MAVROPOULOS J, SYLVESTRE P, ROCKEY DC. The effect of a low-carbohydrate, ketogenic diet on non alcoholic fatty liver disease: a pilot study. Dig Dis Sci 2007; 52: 589-593.
15. VAN DER POORTEN D, MILNER K-L, HUI J, HODGE A, TRENELL MI, KENCH JC. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008; 48: 449-457.
16. PETTA S, MURATORE C, CRAXI A. Non-Alcoholic fatty liver disease pathogenesis: The present and the future. Dig Liver Dis 2009; 41: 615-625.
17. RAUBENHEIMER PJ, NYIRENDA MJ, WALKER BR. A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet. Diabetes 2006; 55: 2015-2020.
18. GHOSHAL AK, FARBE E. New insight into the biochemical pathology of liver in choline deficiency. Crit Rev Biochem Mol Biol 1995; 30: 263-273.
19. KULINSKI A, VANCE DE, VANCE JE. A choline-deficient diet in mice inhibits neither the CDP-choline pathway for phosphatidylcholine synthesis in hepatocytes nor apolipoprotein b secretion. J Biol Chem 2004; 23: 23916-23924.
20. UTZSCHNEIDER KM, KAHN SE. Review: The role of insulin resistance in non alcoholic fatty liver disease. J Clin Endocrinol Metab 2006; 91: 4753-4761.
21. ANDERSON N, BORLAK, J. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol Rev 2008; 60: 311-357.
22. MALHI H, GORES GI. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 2008; 28: 360-369.
23. CAVE M, DEACIUC I, MENDEZ C, SONG Z, JOSHI-BARVE S, BRAVE S, MC CLAIN C. Non-Alcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem 2007; 18: 184-195.
24. YIN M, IKEJIMA K, ARTEEL GE. Glycine accelerates recovery from alcohol-induced liver injury. J Pharmacol Exp Ther 1998; 286: 1014-1019.
25. EL HAFIDI M, PEREZ I, ZAMORA J, SOTO V, CARVAJALSANDOVAL G, BANOS G. Glycine intake decreases plasma free fatty acids, adipose cell size, and blood pressure in sucrose-fed rats. Am J Physiol Regul Integr Comp Physiol 2004; 287: R1387-R1393.
26. SANCHEZ A, HUBBARD RW, SMIT E, HILTON GF. Testing a mechanism of control in human cholesterol metabolism: relation of arginine and glycine to insulin and glucagon. Atherosclerosis 1988; 71: 87-92.
27. PARK T, OH J, LEE K. Dietary taurine or glycine supplementation reduces plasma and liver cholesterol and triglyceride concentrations in rats fed a cholesterol-free diet. Nutr Res 1999; 19: 1777-1789.
28. LYNCH JW. Molecular structure of the glycine receptor chloride channel. Physiol. Rev 2004; 84: 1051-1059.
29. WHEELER M, STACHLEWITZ RF, YAMASHINA S, IKEHIMA K, MORROW AL, THURMAN RG. Glycine gated chloride channels in neutrophiles attenuate calcium influx and superoxide production. Faseb J 2000; 14: 476-484.
30. GARCIA-MACEDO R, SANCHEZ-MUNOZ F, ALMANZA-PEREZ JC, DURAN-REYES G, ALARCON-AGUILAR F, CRUZ M. Glycine increases m RNA adiponectin and diminishes pro-inflammatory adipoknes expression in 3T3-L1 cells. Eur J Pharmacol 2008; 587: 317-321.
31. AJUWON KM, SPURLOCK ME. Adiponectin inhibits LPS-induced NF-kappa B activation and IL-6 production and increases PPAR ã2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 2005; 288: R1220-R1225.
32. FASSHAUER M, KLEIN J, LOSSNER U, PASCHKE R. Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumor necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes. Horm Metab Res 2003; 35: 147-152.
33. ROTTER V, NAGAEV I, SMITH U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-Alpha, overexpressed in human fat cells from insulin resistance subjects. J Biol Chem 2003; 278: 45777-45784.
34. OUCHI N, KIHARA S, FUNASHI T, MATSUZAWA Y, NALSH K. Obasity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003; 14: 561-566.
35. NISHIKAWA T, ARAKI L. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 2007; 9: 343-353.